BREAKING: Chelsea Reach Agreement to Sign Attacker – Medical Done After Player Said Yes to Chelsea

Chelsea
Photo: Getty images

Chelsea have reached an agreement to sign highly-rated Portuguese attacker Geovany Quenda from Sporting CP, with transfer expert Fabrizio Romano confirming the deal as a “here we go!” moment.

The 17-year-old rising star has already completed his medical after a swift and under-the-radar operation by Chelsea, ensuring they secured his signature ahead of other potential suitors. According to Romano, Quenda will officially join the Blues in 2026, allowing him to continue his development before making the move to Stamford Bridge.

Why Chelsea Moved for Quenda

Quenda, a versatile forward with impressive technical ability and flair, has been one of the brightest prospects emerging from Sporting’s academy. Chelsea’s decision to act swiftly reflects their long-term transfer strategy of securing elite young talents before their market value skyrockets.

The club-to-club agreement with Sporting CP has been finalized, and Quenda has personally given the green light to the move, reportedly convinced by Chelsea’s ambitious project and new head coach Enzo Maresca’s vision.

Another Smart Addition to Chelsea’s Youth-Focused Project

Chelsea’s transfer strategy under co-owner Todd Boehly has been heavily focused on recruiting young, high-potential talents for the future. The Blues have already secured top young talents like Kendry Páez, and Estevão Willian, and Quenda’s addition further reinforces this long-term approach.

While he won’t immediately join the first team, Chelsea fans will be excited about what’s to come. The Portuguese forward is expected to continue his development before making his mark at Stamford Bridge.

With this latest acquisition, Chelsea have once again shown their commitment to building a squad for sustained success in the coming years.

Be the first to comment on "BREAKING: Chelsea Reach Agreement to Sign Attacker – Medical Done After Player Said Yes to Chelsea"

Leave a comment

Your email address will not be published.


*